Search results for "Highlights"
Statins may affect diabetes risk primarily in patients with prediabetes
There was a dose-response relationship between statin use and new diabetes diagnoses, with most cases seen in patients whose glycemic markers were close to the diagnostic threshold for diabetes at baseline, an individual-patient meta-analysis found.
https://diabetes.acponline.org/archives/2024/04/12/2.htm
12 Apr 2024
About 5 in 1,000 U.S. adults have type 1 diabetes, 4 in 1,000 kids
In addition to a U.S. study assessing rates of type 1 diabetes in different age groups, a Swedish study looked at differences by age in whether patients' relatives also had the disease, finding that it was likely more tied to genetics in childhood-onset cases.
https://diabetes.acponline.org/archives/2024/04/12/3.htm
12 Apr 2024
ICU patients have higher mortality with blood glucose level above 190 mg/dL
In-hospital mortality risk incrementally increased with every 10% rise in the range from 190 mg/dL to 250 mg/dL, according to a study of critically ill patients with and without diabetes in Chinese ICUs.
https://diabetes.acponline.org/archives/2024/04/12/1.htm
12 Apr 2024
Position statement calls for prioritizing patients' experience in diabetes care
The Endocrine Society's recommendations are based on roundtable meetings with representatives from governmental and other organizations, patient advocacy groups, and professional societies, including ACP.
https://diabetes.acponline.org/archives/2024/03/08/3.htm
8 Mar 2024
Real-time and intermittently scanned CGM associated with improved glycemic control in type 2 diabetes
A meta-analysis of 12 trials found that continuous glucose monitoring (CGM) resulted in an average difference in HbA1c of −0.31% versus self-monitoring, with a trend toward a larger effect with real-time monitoring.
https://diabetes.acponline.org/archives/2024/03/08/2.htm
8 Mar 2024
Basal insulin does not contribute to emotional distress in type 2 diabetes, study finds
A randomized trial found no evidence that basal insulin affected emotional distress and indicated that insulin glargine and liraglutide were associated with a modest decrease in diabetes-related distress at one year.
https://diabetes.acponline.org/archives/2024/03/08/1.htm
8 Mar 2024
Certain beverages associated with CVD risk in type 2 diabetes patients
For each increase of one unit per day in consumption of sugar-sweetened beverages, artificially sweetened beverages, and natural juices, risk for cardiovascular disease (CVD) was 11%, 9%, and 16% higher, respectively, a study of U.K. data found. Coffee and tea were not associated with CVD.
https://diabetes.acponline.org/archives/2024/02/09/2.htm
9 Feb 2024
SGLT-2 inhibitors associated with lower risk of kidney stones vs. other new diabetes drugs
Possible mechanisms to explain the association include increased urinary citrate excretion, increased urinary bicarbonate excretion that raises urine pH, or anti-inflammatory effects.
https://diabetes.acponline.org/archives/2024/02/09/3.htm
9 Feb 2024
Liraglutide had best outcomes in trial of second-line therapies added to metformin
Patients randomized to liraglutide had a 60.3% risk of reaching a composite outcome of glycemic deterioration, weight gain, or hypoglycemia compared with 81.4% on glimepiride, 71.9% on glargine, and 69.6% on sitagliptin.
https://diabetes.acponline.org/archives/2024/02/09/1.htm
9 Feb 2024
AHA releases scientific statement on diabetic foot ulcers in cardiovascular patients
Qualitative and quantitative research is needed to resolve the reasons behind amputations for diabetic foot ulcers, the American Heart Association (AHA) said.
https://diabetes.acponline.org/archives/2024/01/12/3.htm
12 Jan 2024